Abstract
The effect of heparin therapy was followed in 50 patients treated for thrombo-embolic disease. Individual response to a standard dose of 40,000 units of heparin daily showed a considerable variation and the effect was not constant on subsequent days. Five of the 50 patients developed a serious haemorrhage.
It is proposed that to ensure the adequacy of treatment detectable levels of heparin should be obtained but because of the high risk of bleeding these levels should not be excessive.
The results suggest that control of heparin therapy can be based on the thrombin clotting time. Using this test it is advised that treatment is monitored daily in order to achieve a plasma heparin level of up to 1 mg per 100 ml.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gurewich V., Thomas D. P., Stuart R. K. Some guidelines for heparin therapy of venous thromboembolic disease. JAMA. 1967 Jan 9;199(2):116–118. [PubMed] [Google Scholar]
- HARDEN R. M. A METHOD OF INTRAVENOUS ADMINISTRATION OF HEPARIN IN MYOCARDIAL INFARCTION. Br Med J. 1963 Nov 2;2(5365):1106–1107. doi: 10.1136/bmj.2.5365.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jick H., Slone D., Borda I. T., Shapiro S. Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med. 1968 Aug 8;279(6):284–286. doi: 10.1056/NEJM196808082790603. [DOI] [PubMed] [Google Scholar]
- Kernohan R. J., Todd C. Heparin therapy in thromboembolic disease. Lancet. 1966 Mar 19;1(7438):621–623. doi: 10.1016/s0140-6736(66)90822-1. [DOI] [PubMed] [Google Scholar]
- Pitney W. R., Pettit J. E., Armstrong L. Control of heparin therapy. Br Med J. 1970 Oct 17;4(5728):139–141. doi: 10.1136/bmj.4.5728.139. [DOI] [PMC free article] [PubMed] [Google Scholar]